Literature DB >> 17476146

Effect of early menopause on bone mineral density and fractures.

J Christopher Gallagher1.   

Abstract

OBJECTIVE: To review the data on the effect of early menopause on bone. Do women undergoing early menopause develop lower bone mineral density at an earlier age and do they have a higher incidence of osteoporotic fractures? Is there a difference on bone between women who undergo early natural menopause compared to women who have early menopause after oophorectomy?
RESULTS: The earlier in life that menopause occurs, the lower the bone density will be later in life. Low bone density is associated with a higher fracture rate, and several studies show a relationship between early menopause, oophorectomy, and an increase in osteoporotic fractures.
CONCLUSIONS: Early menopause is a risk factor for osteoporosis. Women with an early menopause should have bone density testing performed within 10 years of menopause so that osteopenia or osteoporosis will be diagnosed early and appropriate anti-resorptive therapy initiated.

Entities:  

Mesh:

Year:  2007        PMID: 17476146     DOI: 10.1097/gme.0b013e31804c793d

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  77 in total

Review 1.  Premature menopause or early menopause: long-term health consequences.

Authors:  Lynne T Shuster; Deborah J Rhodes; Bobbie S Gostout; Brandon R Grossardt; Walter A Rocca
Journal:  Maturitas       Date:  2009-09-05       Impact factor: 4.342

Review 2.  The genetics of bone loss: challenges and prospects.

Authors:  Braxton D Mitchell; Laura M Yerges-Armstrong
Journal:  J Clin Endocrinol Metab       Date:  2011-02-23       Impact factor: 5.958

Review 3.  Long-term health consequences of premature or early menopause and considerations for management.

Authors:  S S Faubion; C L Kuhle; L T Shuster; W A Rocca
Journal:  Climacteric       Date:  2015-04-07       Impact factor: 3.005

4.  Exposure to di(2-ethylhexyl) phthalate and diisononyl phthalate during adulthood disrupts hormones and ovarian folliculogenesis throughout the prime reproductive life of the mouse.

Authors:  Catheryne Chiang; Lily R Lewis; Grace Borkowski; Jodi A Flaws
Journal:  Toxicol Appl Pharmacol       Date:  2020-03-10       Impact factor: 4.219

5.  Use of antimüllerian hormone to predict the menopausal transition in HIV-infected women.

Authors:  Rebecca Scherzer; Ruth M Greenblatt; Zaher O Merhi; Seble Kassaye; Geralyn Lambert-Messerlian; Pauline M Maki; Kerry Murphy; Roksana Karim; Peter Bacchetti
Journal:  Am J Obstet Gynecol       Date:  2016-07-26       Impact factor: 8.661

6.  Bone mineral density, body mass index, postmenopausal period and outcomes of low back pain treatment in Korean postmenopausal women.

Authors:  Jongbae J Park; Joonshik Shin; Yousuk Youn; Catherine Champagne; Eunseok Jin; Soonsung Hong; Kwanhye Jung; Sangho Lee; Sunkyu Yeom
Journal:  Eur Spine J       Date:  2010-09-01       Impact factor: 3.134

7.  Osteoporosis onset differences between rural and metropolitan populations: correlation to fracture type, severity, and treatment efficacy.

Authors:  Thomas Pagonis; Panagiotis Givissis; Athanasios Pagonis; Georgios Petsatodis; Anastasios Christodoulou
Journal:  J Bone Miner Metab       Date:  2011-06-14       Impact factor: 2.626

Review 8.  Osteoporosis in celiac disease and in endocrine and reproductive disorders.

Authors:  Anna-Velia Stazi; Antonello Trecca; Biagino Trinti
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

Review 9.  Long-term Toxicity of Cancer Treatment in Older Patients.

Authors:  Armin Shahrokni; Abraham J Wu; Jeanne Carter; Stuart M Lichtman
Journal:  Clin Geriatr Med       Date:  2015-10-13       Impact factor: 3.076

10.  Fracture, bone mineral density, and the effects of calcitonin receptor gene in postmenopausal Koreans.

Authors:  H-J Lee; S-Y Kim; G S Kim; J-Y Hwang; Y-J Kim; B Jeong; T-H Kim; E K Park; S H Lee; H-L Kim; J-M Koh; J-Y Lee
Journal:  Osteoporos Int       Date:  2009-11-28       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.